Asuragen Inks Distribution Deal for France

Biomedical Diagnostics will distribute Asuragen's RT-PCR-based cancer assays in France and will help set up validation sites for the firm's KRAS/BRAF tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories